Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS
- 13 September 2019
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 26 (1) , 41-51
Abstract
Neurocognitive impairment (NCI) among HIV-infected patients is heterogeneous in its reported presentations and frequencies. To determine the prevalence of NCI and its associated subtypes as well as predictive variables, we investigated patients with HIV/AIDS receiving universal health care. Recruited adult HIV-infected subjects underwent a neuropsychological (NP) test battery with established normative (sex-, age-, and education-matched) values together with assessment of their demographic and clinical variables. Three patient groups were identified including neurocognitively normal (NN, n = 246), HIV-associated neurocognitive disorders (HAND, n = 78), and neurocognitively impaired-other disorders (NCI-OD, n = 46). Univariate, multiple logistic regression and machine learning analyses were applied. Univariate analyses showed variables differed significantly between groups including birth continent, quality of life, substance use, and PHQ-9. Multiple logistic regression models revealed groups again differed significantly for substance use, PHQ-9 score, VACS index, and head injury. Random forest (RF) models disclosed that classification algorithms distinguished HAND from NN and NCI-OD from NN with area under the curve (AUC) values of 0.87 and 0.77, respectively. Relative importance plots derived from the RF model exhibited distinct variable rankings that were predictive of NCI status for both NN versus HAND and NN versus NCI-OD comparisons. Thus, NCI was frequently detected (33.5%) although HAND prevalence (21%) was lower than in several earlier reports underscoring the potential contribution of other factors to NCI. Machine learning models uncovered variables related to individual NCI types that were not identified by univariate or multiple logistic regression analyses, highlighting the value of other approaches to understanding NCI in HIV/AIDS.Keywords
Funding Information
- Canadian Institutes of Health Research (157986)
This publication has 33 references indexed in Scilit:
- Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDSThe Canadian Journal of Psychiatry, 2017
- Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort StudyAIDS Patient Care and STDs, 2017
- HIV-associated neurocognitive disorder — pathogenesis and prospects for treatmentNature Reviews Neurology, 2016
- Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infectionAIDS, 2015
- Mini-Cog PerformanceCirculation: Heart Failure, 2015
- Life expectancy living with HIVCurrent Opinion in Infectious Diseases, 2013
- Random forest-based similarity measures for multi-modal classification of Alzheimer's diseaseNeuroImage, 2013
- Predictors of symptomatic HIV‐associated neurocognitive disorders in universal health careHIV Medicine, 2012
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapyNeurology, 2010
- The PHQ-9Journal of General Internal Medicine, 2001